Pluristyx, a biotechnology company, has executed two commercial clinical use licensing agreements. These agreements provide access to Pluristyx’s clinical-grade iPSC lines and gene engineering platform
For parents of children with Autism Spectrum Disorder (ASD), exploring treatment options can be a journey filled with questions and uncertainty. One of the emerging
IN8bio, a clinical-stage biopharmaceutical company, has expanded its Phase 1 clinical trial for INB-100. The Ohio State University is now a new clinical site for
Do you ever feel unwell, but your doctor says all your tests are normal? You are not alone. Many people experience a state of feeling
Are you curious about the true potential of stem cell therapy? Many people have questions and concerns about the ethics and effectiveness of this groundbreaking
Modern medicine is on the cusp of a transformation that could rival the impact of antibiotics. Just as antibiotics revolutionized the treatment of infectious diseases,
The Jackson Laboratory (JAX), a global leader in genetics and genomic medicine, has acquired the New York Stem Cell Foundation (NYSCF). This strategic unification creates
Unlocking the Secrets of Stem Cells Have you ever wondered if the human body could heal itself more effectively? New research on a tiny worm
A New Hope for Patients with Diabetic Foot Ulcers and Peripheral Artery Disease Do you or someone you know struggle with the healing of diabetic
Have you ever wondered how your body recovers from daily wear and tear? The answer lies in a remarkable internal force: your body’s natural repair system.